{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:05:53Z","timestamp":1773921953327,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T00:00:00Z","timestamp":1766534400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Hebei Provincial Health and Family Planning Commission Research Fund Project"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Hum Hypertens"],"DOI":"10.1038\/s41371-025-01110-9","type":"journal-article","created":{"date-parts":[[2025,12,24]],"date-time":"2025-12-24T06:15:50Z","timestamp":1766556950000},"page":"180-187","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Serum levels of placenta growth factor, adiponectin and endothelin-1 correlate to the occurrence and outcomes of hypertensive disorders complicating pregnancy"],"prefix":"10.1038","volume":"40","author":[{"given":"Shasha","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianyu","family":"Lan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiefang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liman","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanlei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,24]]},"reference":[{"key":"1110_CR1","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1136\/jim-2017-000626","volume":"66","author":"F Lei","year":"2018","unstructured":"Lei F, Liu D, Shen Y, Zhang L, Li S, Liu X, et al. Study on the influence of pregnancy-induced hypertension on neonatal birth weight. J. Investig. Med. 2018;66:1008\u201314.","journal-title":"J. Investig. Med."},{"key":"1110_CR2","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/AOG.0000000000002115","volume":"130","author":"PS Bernstein","year":"2017","unstructured":"Bernstein PS, Martin JN Jr., Barton JR, Shields LE, Druzin ML, Scavone BM, et al. National partnership for maternal safety: consensus bundle on severe hypertension during pregnancy and the postpartum period. Obstet. Gynecol. 2017;130:347\u201357.","journal-title":"Obstet. Gynecol."},{"key":"1110_CR3","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.jogn.2017.05.003","volume":"46","author":"PS Bernstein","year":"2017","unstructured":"Bernstein PS, Martin JN Jr., Barton JR, Shields LE, Druzin ML, Scavone BM, et al. Consensus bundle on severe hypertension during pregnancy and the postpartum period. J. Obstet. Gynecol. Neonatal Nurs. 2017;46:776\u201387.","journal-title":"J. Obstet. Gynecol. Neonatal Nurs."},{"key":"1110_CR4","doi-asserted-by":"publisher","first-page":"e023562","DOI":"10.1136\/bmjopen-2018-023562","volume":"9","author":"D Hayes-Ryan","year":"2019","unstructured":"Hayes-Ryan D, Hemming K, Breathnach F, Cotter A, Devane D, Hunter A, et al. PARROT ireland: placental growth factor in assessment of women with suspected pre-eclampsia to reduce maternal morbidity: a stepped wedge cluster randomised control trial research study protocol. BMJ Open. 2019;9:e023562.","journal-title":"BMJ Open."},{"key":"1110_CR5","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.placenta.2012.03.003","volume":"33","author":"G Di Lorenzo","year":"2012","unstructured":"Di Lorenzo G, Ceccarello M, Cecotti V, Ronfani L, Monasta L, Vecchi Brumatti L, et al. First trimester maternal serum PIGF, free beta-hCG, PAPP-A, PP-13, uterine artery doppler and maternal history for the prediction of preeclampsia. Placenta. 2012;33:495\u2013501.","journal-title":"Placenta"},{"key":"1110_CR6","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1515\/jpm-2024-0184","volume":"53","author":"G Qi","year":"2024","unstructured":"Qi G, Yao L, Liu Z, Guo W, Liu H, Zhang J, et al. Placental growth factor as a predictive marker of preeclampsia in twin pregnancy. J. Perinat. Med. 2024;53:149\u201357.","journal-title":"J. Perinat. Med."},{"key":"1110_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/s12896-024-00891-0","volume":"24","author":"S Mallawarachchi","year":"2024","unstructured":"Mallawarachchi S, Cebecioglu RE, Althumayri M, Beker L, Fernando S, Ceylan Koydemir H. Systematic design and evaluation of aptamers for VEGF and PlGF biomarkers of Preeclampsia. BMC Biotechnol. 2024;24:64.","journal-title":"BMC Biotechnol."},{"key":"1110_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","volume":"257","author":"Y Arita","year":"1999","unstructured":"Arita Y, Kihara S, Ouchi N, Takahashi M, Maeda K, Miyagawa J, et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 1999;257:79\u201383.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1110_CR9","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1161\/01.ATV.20.6.1595","volume":"20","author":"K Hotta","year":"2000","unstructured":"Hotta K, Funahashi T, Arita Y, Takahashi M, Matsuda M, Okamoto Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler. Thromb. Vasc. Biol. 2000;20:1595\u20139.","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1110_CR10","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1007\/s00125-003-1074-z","volume":"46","author":"M Cnop","year":"2003","unstructured":"Cnop M, Havel PJ, Utzschneider KM, Carr DB, Sinha MK, Boyko EJ, et al. Relationship of adiponectin to body fat distribution, insulin sensitivity and plasma lipoproteins: evidence for independent roles of age and sex. Diabetologia. 2003;46:459\u201369.","journal-title":"Diabetologia"},{"key":"1110_CR11","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1161\/CIRCRESAHA.121.318093","volume":"128","author":"M Koenen","year":"2021","unstructured":"Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, adipose tissue and vascular dysfunction. Circ. Res. 2021;128:951\u201368.","journal-title":"Circ. Res."},{"key":"1110_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2024.167488","volume":"1870","author":"A Mou","year":"2024","unstructured":"Mou A, Sun F, Tong D, Wang L, Lu Z, Cao T, et al. Dietary apigenin ameliorates obesity-related hypertension through TRPV4-dependent vasorelaxation and TRPV4-independent adiponectin secretion. Biochim. Biophys. Acta Mol. Basis Dis. 2024;1870:167488.","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"key":"1110_CR13","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1161\/01.CIR.100.25.2473","volume":"100","author":"N Ouchi","year":"1999","unstructured":"Ouchi N, Kihara S, Arita Y, Maeda K, Kuriyama H, Okamoto Y, et al. Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin. Circulation. 1999;100:2473\u20136.","journal-title":"Circulation"},{"key":"1110_CR14","doi-asserted-by":"publisher","DOI":"10.1080\/01443615.2023.2232656","volume":"43","author":"Z Zhang","year":"2023","unstructured":"Zhang Z, Liu F, Zhang Q, Li D, Cai L. Umbilical artery ultrasound haemodynamics combined with serum adiponectin levels can aid in predicting adverse pregnancy outcomes in patients with severe pre-eclampsia. J. Obstet. Gynaecol. 2023;43:2232656.","journal-title":"J. Obstet. Gynaecol."},{"key":"1110_CR15","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1161\/01.CIR.89.3.1320","volume":"89","author":"M Yanagisawa","year":"1994","unstructured":"Yanagisawa M. The endothelin system. a new target for therapeutic intervention. Circulation. 1994;89:1320\u20132.","journal-title":"Circulation"},{"key":"1110_CR16","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00418-001-0368-9","volume":"117","author":"JA van Mourik","year":"2002","unstructured":"van Mourik JA, Romani de Wit T, Voorberg J. Biogenesis and exocytosis of Weibel-Palade bodies. Histochem. Cell Biol. 2002;117:113\u201322.","journal-title":"Histochem. Cell Biol."},{"key":"1110_CR17","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/S0031-6997(25)06809-7","volume":"46","author":"GM Rubanyi","year":"1994","unstructured":"Rubanyi GM, Polokoff MA. Endothelins: molecular biology, biochemistry, pharmacology, physiology, and pathophysiology. Pharmacol. Rev. 1994;46:325\u2013415.","journal-title":"Pharmacol. Rev."},{"key":"1110_CR18","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1161\/HYPERTENSIONAHA.115.05168","volume":"66","author":"Y Rautureau","year":"2015","unstructured":"Rautureau Y, Coelho SC, Fraulob-Aquino JC, Huo KG, Rehman A, Offermanns S, et al. Inducible human endothelin-1 overexpression in endothelium raises blood pressure via endothelin type A receptors. Hypertension. 2015;66:347\u201355.","journal-title":"Hypertension"},{"key":"1110_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.55133\/eji.300210","volume":"30","author":"MA Othman","year":"2023","unstructured":"Othman MA, Badawy ER, Sobh AMA, Shaltout AS, Mostafa SA. Effect of 17-hydroxyprogesterone caproate on interleukin-6 and tumor necrosis factor-alpha in expectantly managed early-onset preeclampsia. Egypt. J. Immunol. 2023;30:109\u201318.","journal-title":"Egypt. J. Immunol."},{"key":"1110_CR20","first-page":"121","volume":"93","author":"L Leeman","year":"2016","unstructured":"Leeman L, Dresang LT, Fontaine P. Hypertensive disorders of pregnancy. Am. Fam. Physician. 2016;93:121\u20137.","journal-title":"Am. Fam. Physician"},{"key":"1110_CR21","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/hr.2016.126","volume":"40","author":"M Umesawa","year":"2017","unstructured":"Umesawa M, Kobashi G. Epidemiology of hypertensive disorders in pregnancy: prevalence, risk factors, predictors and prognosis. Hypertens. Res. 2017;40:213\u201320.","journal-title":"Hypertens. Res."},{"key":"1110_CR22","doi-asserted-by":"publisher","first-page":"e100180","DOI":"10.1371\/journal.pone.0100180","volume":"9","author":"C Ye","year":"2014","unstructured":"Ye C, Ruan Y, Zou L, Li G, Li C, Chen Y, et al. The 2011 survey on hypertensive disorders of pregnancy (HDP) in China: prevalence, risk factors, complications, pregnancy and perinatal outcomes. PLoS One. 2014;9:e100180.","journal-title":"PLoS One"},{"key":"1110_CR23","unstructured":"Deng Li FB Clinical epidemiological analysis of hypertensive disorders in pregnancy. Hainan Med. J. 2015;17"},{"key":"1110_CR24","unstructured":"Zhao W, Di J, Huang A, Qi Y, Hu H. The incidence and risk factors of hypertensive disorders of pregnancy in inpatient deliveries in Ningbo city: trend analysis from 2016 to 2020. Chinese Journal of Hypertension 2022;6:751\u201360."},{"key":"1110_CR25","first-page":"119","volume":"100","author":"R Komwilaisak","year":"2017","unstructured":"Komwilaisak R, Tangkiratichai P. Maternal serum angiogenic growth factors in intrauterine growth restriction versus normal pregnancies. J. Med. Assoc. Thai. 2017;100:119\u201324.","journal-title":"J. Med. Assoc. Thai."},{"key":"1110_CR26","first-page":"3","volume":"22","author":"Zhao Zhang cong Hr","year":"2018","unstructured":"Zhang cong Hr Zhao, Cuisheng Wang. hongzhou. Diagnostic value of serum PIGF, sFlt-1 and sEng combined in predicting the onset of preeclampsia in pregnant women. Chin. Exp. diagnostics. 2018;22:3.","journal-title":"Chin. Exp. diagnostics"},{"key":"1110_CR27","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1056\/NEJMoa031884","volume":"350","author":"RJ Levine","year":"2004","unstructured":"Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, et al. Circulating angiogenic factors and the risk of preeclampsia. N. Engl. J. Med. 2004;350:672\u201383.","journal-title":"N. Engl. J. Med."},{"key":"1110_CR28","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1172\/JCI17189","volume":"111","author":"SE Maynard","year":"2003","unstructured":"Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J. Clin. Invest. 2003;111:649\u201358.","journal-title":"J. Clin. Invest."},{"key":"1110_CR29","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1097\/01.AOG.0000168441.79050.03","volume":"106","author":"R D\u2019Anna","year":"2005","unstructured":"D\u2019Anna R, Baviera G, Corrado F, Giordano D, Di Benedetto A, Jasonni VM. Plasma adiponectin concentration in early pregnancy and subsequent risk of hypertensive disorders. Obstet. Gynecol. 2005;106:340\u20134.","journal-title":"Obstet. Gynecol."},{"key":"1110_CR30","first-page":"4","volume":"26","author":"ZZ Miaomiao","year":"2011","unstructured":"Miaomiao ZZ. Expression and significance of adiponectin and resistin mRNA in placenta and maternal blood of preeclampsia patients. Matern. child. health care China. 2011;26:4.","journal-title":"Matern. child. health care China"},{"key":"1110_CR31","first-page":"2","volume":"30","author":"Y Li","year":"2008","unstructured":"Li Xiaohong Y, Chang Y. Changes of serum adiponectin and lipid levels in patients with preeclampsia. Hebei Pharm. 2008;30:2.","journal-title":"Hebei Pharm."},{"key":"1110_CR32","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.preghy.2020.03.010","volume":"20","author":"R Mhiri","year":"2020","unstructured":"Mhiri R, Mvogo A, Kamga A, Yassinguezo S, Fagla H, Dotou D, et al. Epidemiology and maternal prognosis of hypertension disorders of pregnancy in French Guiana. Pregnancy Hypertens. 2020;20:96\u2013101.","journal-title":"Pregnancy Hypertens."},{"key":"1110_CR33","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/ajh.2007.10","volume":"21","author":"G Mule","year":"2008","unstructured":"Mule G, Cottone S, Cusimano P, Incalcaterra F, Giandalia M, Costanzo M, et al. Inverse relationship between ambulatory arterial stiffness index and glomerular filtration rate in arterial hypertension. Am. J. Hypertens. 2008;21:35\u201340.","journal-title":"Am. J. Hypertens."},{"key":"1110_CR34","doi-asserted-by":"publisher","first-page":"2318","DOI":"10.1210\/jcem.85.6.6623","volume":"85","author":"M Napolitano","year":"2000","unstructured":"Napolitano M, Miceli F, Calce A, Vacca A, Gulino A, Apa R, et al. Expression and relationship between endothelin-1 messenger ribonucleic acid (mRNA) and inducible\/endothelial nitric oxide synthase mRNA isoforms from normal and preeclamptic placentas. J. Clin. Endocrinol. Metab. 2000;85:2318\u201323.","journal-title":"J. Clin. Endocrinol. Metab."}],"container-title":["Journal of Human Hypertension"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01110-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01110-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01110-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T07:47:40Z","timestamp":1773906460000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41371-025-01110-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,24]]},"references-count":34,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["1110"],"URL":"https:\/\/doi.org\/10.1038\/s41371-025-01110-9","relation":{},"ISSN":["1476-5527"],"issn-type":[{"value":"1476-5527","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,24]]},"assertion":[{"value":"8 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Fourth Hospital of Shijiazhuang, and written informed consent was derived from the participants. The study was performed in strict accordance with the Declaration of Helsinki, Ethical Principles for Medical Research Involving Human Subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}